Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor
Clinical trial NCT01372618 · TERMINATED
Trial details
- NCT number
- NCT01372618
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2015-10-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.